Tânia Pereira

Abstract
The early and accurate detection and the grading characterization of brain cancer will generate a positive impact on the treatment plan of those patients. AI-based models can help analyze the Magnetic Resonance Imaging (MRI) to make an initial assessment of the tumor grading. The objective of this work was to develop an Al-based model to classify the grading of the tumor using the MRI. Two regions of interest were explored, with several levels of complexity for the neural network architecture, and Iwo strategies to deal with Unbalanced data. The best results were obtained for the most complex architecture (Resnet50) with a combination of weighted random sampler and data augmentation achieving a balanced accuracy of 62.26%. This work confirmed that complex problems required a more dense neural network and strategies to deal with the unbalanced data.

Abstract
Recent studies have shown that the microbiome can impact cancer development, progression, and response to therapies suggesting microbiome-based approaches for cancer characterization. As cancer-related signatures are complex and implicate many taxa, their discovery often requires Machine Learning approaches. This review discusses Machine Learning methods for cancer characterization from microbiome data. It focuses on the implications of choices undertaken during sample collection, feature selection and pre-processing. It also discusses ML model selection, guiding how to choose an ML model, and model validation. Finally, it enumerates current limitations and how these may be surpassed. Proposed methods, often based on Random Forests, show promising results, however insufficient for widespread clinical usage. Studies often report conflicting results mainly due to ML models with poor generalizability. We expect that evaluating models with expanded, hold-out datasets, removing technical artifacts, exploring representations of the microbiome other than taxonomical profiles, leveraging advances in deep learning, and developing ML models better adapted to the characteristics of microbiome data will improve the performance and generalizability of models and enable their usage in the clinic.

Abstract
Lung Cancer (LC) is still among the top main causes of death worldwide, and it is the leading death number among other cancers. Several AI-based methods have been developed for the early detection of LC, trying to use Computed Tomography (CT) images to identify the initial signs of the disease. The survival prediction could help the clinicians to adequate the treatment plan and all the proceedings, by the identification of the most severe cases that need more attention. In this study, several deep learning models were compared to predict the survival of LC patients using CT images. The best performing model, a CNN with 3 layers, achieved an AUC value of 0.80, a Precision value of 0.56 and a Recall of 0.64. The obtained results showed that CT images carry information that can be used to assess the survival of LC.

Abstract
Currently, lung cancer is one of the deadliest diseases that affects millions of people globally. However, Artificial Intelligence is being increasingly integrated with healthcare practices, with the goal to aid in the early diagnosis of lung cancer. Although such methods have shown very promising results, they still lack transparency to the user, which consequently could make their generalised adoption a challenging task. Therefore, in this work we explore the use of post-hoc explainable methods, to better understand the inner-workings of an already established multitasking framework that executes the segmentation and the classification task of lung nodules simultaneously. The idea behind such study is to understand how a multitasking approach impacts the model's performance in the lung nodule classification task when compared to single-task models. Our results show that the multitasking approach works as an attention mechanism by aiding the model to learn more meaningful features. Furthermore, the multitasking framework was able to achieve a better performance in regard to the explainability metric, with an increase of 7% when compared to our baseline, and also during the classification and segmentation task, with an increase of 4.84% and 15.03%; for each task respectively, when also compared to the studied baselines.

Abstract
Artificial Intelligence (AI) is one of the big hopes for the future of a positive revolution in the use of medical data to improve clinical routine and personalized medicine [...]